A new prognostic histopathologic classification of nasopharyngeal carcinoma

Abstract Background The current World Health Organization (WHO) classification of nasopharyngeal carcinoma (NPC) conveys little prognostic information. This study aimed to propose an NPC histopathologic classification that can potentially be used to predict prognosis and treatment response. Methods...

Full description

Bibliographic Details
Main Authors: Hai-Yun Wang, Yih-Leong Chang, Ka-Fai To, Jacqueline S. G. Hwang, Hai-Qiang Mai, Yan-Fen Feng, Ellen T. Chang, Chen-Ping Wang, Michael Koon Ming Kam, Shie-Lee Cheah, Ming Lee, Li Gao, Hui-Zhong Zhang, Jie-Hua He, Hao Jiang, Pei-Qing Ma, Xiao-Dong Zhu, Liang Zeng, Chun-Yan Chen, Gang Chen, Ma-Yan Huang, Sha Fu, Qiong Shao, An-Jia Han, Hai-Gang Li, Chun-Kui Shao, Pei-Yu Huang, Chao-Nan Qian, Tai-Xiang Lu, Jin-Tian Li, Weimin Ye, Ingemar Ernberg, Ho Keung Ng, Joseph T. S. Wee, Yi-Xin Zeng, Hans-Olov Adami, Anthony T. C. Chan, Jian-Yong Shao
Format: Article
Language:English
Published: BMC 2016-05-01
Series:Chinese Journal of Cancer
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40880-016-0103-5
_version_ 1818932804405166080
author Hai-Yun Wang
Yih-Leong Chang
Ka-Fai To
Jacqueline S. G. Hwang
Hai-Qiang Mai
Yan-Fen Feng
Ellen T. Chang
Chen-Ping Wang
Michael Koon Ming Kam
Shie-Lee Cheah
Ming Lee
Li Gao
Hui-Zhong Zhang
Jie-Hua He
Hao Jiang
Pei-Qing Ma
Xiao-Dong Zhu
Liang Zeng
Chun-Yan Chen
Gang Chen
Ma-Yan Huang
Sha Fu
Qiong Shao
An-Jia Han
Hai-Gang Li
Chun-Kui Shao
Pei-Yu Huang
Chao-Nan Qian
Tai-Xiang Lu
Jin-Tian Li
Weimin Ye
Ingemar Ernberg
Ho Keung Ng
Joseph T. S. Wee
Yi-Xin Zeng
Hans-Olov Adami
Anthony T. C. Chan
Jian-Yong Shao
author_facet Hai-Yun Wang
Yih-Leong Chang
Ka-Fai To
Jacqueline S. G. Hwang
Hai-Qiang Mai
Yan-Fen Feng
Ellen T. Chang
Chen-Ping Wang
Michael Koon Ming Kam
Shie-Lee Cheah
Ming Lee
Li Gao
Hui-Zhong Zhang
Jie-Hua He
Hao Jiang
Pei-Qing Ma
Xiao-Dong Zhu
Liang Zeng
Chun-Yan Chen
Gang Chen
Ma-Yan Huang
Sha Fu
Qiong Shao
An-Jia Han
Hai-Gang Li
Chun-Kui Shao
Pei-Yu Huang
Chao-Nan Qian
Tai-Xiang Lu
Jin-Tian Li
Weimin Ye
Ingemar Ernberg
Ho Keung Ng
Joseph T. S. Wee
Yi-Xin Zeng
Hans-Olov Adami
Anthony T. C. Chan
Jian-Yong Shao
author_sort Hai-Yun Wang
collection DOAJ
description Abstract Background The current World Health Organization (WHO) classification of nasopharyngeal carcinoma (NPC) conveys little prognostic information. This study aimed to propose an NPC histopathologic classification that can potentially be used to predict prognosis and treatment response. Methods We initially developed a histopathologic classification based on the morphologic traits and cell differentiation of tumors of 2716 NPC patients who were identified at Sun Yat-sen University Cancer Center (SYSUCC) (training cohort). Then, the proposed classification was applied to 1702 patients (retrospective validation cohort) from hospitals outside SYSUCC and 1613 patients (prospective validation cohort) from SYSUCC. The efficacy of radiochemotherapy and radiotherapy modalities was compared between the proposed subtypes. We used Cox proportional hazards models to estimate hazard ratios (HRs) with 95% confidence intervals (CI) for overall survival (OS). Results The 5-year OS rates for all NPC patients who were diagnosed with epithelial carcinoma (EC; 3708 patients), mixed sarcomatoid-epithelial carcinoma (MSEC; 1247 patients), sarcomatoid carcinoma (SC; 823 patients), and squamous cell carcinoma (SCC; 253 patients) were 79.4%, 70.5%, 59.6%, and 42.6%, respectively (P < 0.001). In multivariate models, patients with MSEC had a shorter OS than patients with EC (HR = 1.44, 95% CI = 1.27–1.62), SC (HR = 2.00, 95% CI = 1.76–2.28), or SCC (HR = 4.23, 95% CI = 3.34–5.38). Radiochemotherapy significantly improved survival compared with radiotherapy alone for patients with EC (HR = 0.67, 95% CI = 0.56–0.80), MSEC (HR = 0.58, 95% CI = 0.49–0.75), and possibly for those with SCC (HR = 0.63; 95% CI = 0.40–0.98), but not for patients with SC (HR = 0.97, 95% CI = 0.74–1.28). Conclusions The proposed classification offers more information for the prediction of NPC prognosis compared with the WHO classification and might be a valuable tool to guide treatment decisions for subtypes that are associated with a poor prognosis.
first_indexed 2024-12-20T04:38:18Z
format Article
id doaj.art-1c07513f8e9d4a92b7d071d9a4fa0feb
institution Directory Open Access Journal
issn 1944-446X
language English
last_indexed 2024-12-20T04:38:18Z
publishDate 2016-05-01
publisher BMC
record_format Article
series Chinese Journal of Cancer
spelling doaj.art-1c07513f8e9d4a92b7d071d9a4fa0feb2022-12-21T19:53:11ZengBMCChinese Journal of Cancer1944-446X2016-05-0135111610.1186/s40880-016-0103-5A new prognostic histopathologic classification of nasopharyngeal carcinomaHai-Yun Wang0Yih-Leong Chang1Ka-Fai To2Jacqueline S. G. Hwang3Hai-Qiang Mai4Yan-Fen Feng5Ellen T. Chang6Chen-Ping Wang7Michael Koon Ming Kam8Shie-Lee Cheah9Ming Lee10Li Gao11Hui-Zhong Zhang12Jie-Hua He13Hao Jiang14Pei-Qing Ma15Xiao-Dong Zhu16Liang Zeng17Chun-Yan Chen18Gang Chen19Ma-Yan Huang20Sha Fu21Qiong Shao22An-Jia Han23Hai-Gang Li24Chun-Kui Shao25Pei-Yu Huang26Chao-Nan Qian27Tai-Xiang Lu28Jin-Tian Li29Weimin Ye30Ingemar Ernberg31Ho Keung Ng32Joseph T. S. Wee33Yi-Xin Zeng34Hans-Olov Adami35Anthony T. C. Chan36Jian-Yong Shao37State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterDepartment of Pathology, National Taiwan University Hospital, National Taiwan University College of MedicineDepartment of Anatomical and Cellular Pathology, Hong Kong Cancer Institute and Sir YK Pao Centre for Cancer, Faculty of Medicine, The Chinese University of Hong KongDepartment of Pathology, Singapore General HospitalState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterDivision of Epidemiology, Department of Health Research and Policy, Stanford University School of MedicineDepartment of Otolaryngology, National Taiwan University Hospital, National Taiwan University College of MedicineDepartment of Clinical Oncology, Hong Kong Cancer Institute and Sir YK Pao Centre for Cancer, Faculty of Medicine, The Chinese University of Hong KongDivision of Radiation Oncology, National Cancer CenterDepartment of Pathology, Singapore General HospitalDepartment of Radiation Oncology, Cancer Institute and Hospital, Chinese Academy of Medical SciencesState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterDepartment of Radiation Oncology, The Affiliated Hospital of Bengbu Medical CollegeDepartment of Pathology, Cancer Institute and Hospital, Chinese Academy of Medical SciencesDepartment of Radiation Oncology, Guangxi Medical UniversityDepartment of Pathology, Hunan Provincial Cancer HospitalState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterDepartment of Pathology, Fujian Provincial Cancer HospitalState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterDepartment of Pathology, The First Affiliated Hospital, Sun Yat-sen UniversityDepartment of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen UniversityDepartment of Pathology, The Third Affiliated Hospital, Sun Yat-sen UniversityState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterDepartment of Pathology, Hunan Provincial Cancer HospitalState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterDepartment of Medical Epidemiology and Biostatistics, Karolinska InstitutetDepartments of Microbiology and Tumor Biology Center, Karolinska InstitutetDepartment of Anatomical and Cellular Pathology, Hong Kong Cancer Institute and Sir YK Pao Centre for Cancer, Faculty of Medicine, The Chinese University of Hong KongDepartment of Clinical Oncology, Hong Kong Cancer Institute and Sir YK Pao Centre for Cancer, Faculty of Medicine, The Chinese University of Hong KongState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterDepartment of Medical Epidemiology and Biostatistics, Karolinska InstitutetDepartment of Clinical Oncology, Hong Kong Cancer Institute and Sir YK Pao Centre for Cancer, Faculty of Medicine, The Chinese University of Hong KongState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterAbstract Background The current World Health Organization (WHO) classification of nasopharyngeal carcinoma (NPC) conveys little prognostic information. This study aimed to propose an NPC histopathologic classification that can potentially be used to predict prognosis and treatment response. Methods We initially developed a histopathologic classification based on the morphologic traits and cell differentiation of tumors of 2716 NPC patients who were identified at Sun Yat-sen University Cancer Center (SYSUCC) (training cohort). Then, the proposed classification was applied to 1702 patients (retrospective validation cohort) from hospitals outside SYSUCC and 1613 patients (prospective validation cohort) from SYSUCC. The efficacy of radiochemotherapy and radiotherapy modalities was compared between the proposed subtypes. We used Cox proportional hazards models to estimate hazard ratios (HRs) with 95% confidence intervals (CI) for overall survival (OS). Results The 5-year OS rates for all NPC patients who were diagnosed with epithelial carcinoma (EC; 3708 patients), mixed sarcomatoid-epithelial carcinoma (MSEC; 1247 patients), sarcomatoid carcinoma (SC; 823 patients), and squamous cell carcinoma (SCC; 253 patients) were 79.4%, 70.5%, 59.6%, and 42.6%, respectively (P < 0.001). In multivariate models, patients with MSEC had a shorter OS than patients with EC (HR = 1.44, 95% CI = 1.27–1.62), SC (HR = 2.00, 95% CI = 1.76–2.28), or SCC (HR = 4.23, 95% CI = 3.34–5.38). Radiochemotherapy significantly improved survival compared with radiotherapy alone for patients with EC (HR = 0.67, 95% CI = 0.56–0.80), MSEC (HR = 0.58, 95% CI = 0.49–0.75), and possibly for those with SCC (HR = 0.63; 95% CI = 0.40–0.98), but not for patients with SC (HR = 0.97, 95% CI = 0.74–1.28). Conclusions The proposed classification offers more information for the prediction of NPC prognosis compared with the WHO classification and might be a valuable tool to guide treatment decisions for subtypes that are associated with a poor prognosis.http://link.springer.com/article/10.1186/s40880-016-0103-5Nasopharyngeal carcinomaPathologic classificationPrognosis
spellingShingle Hai-Yun Wang
Yih-Leong Chang
Ka-Fai To
Jacqueline S. G. Hwang
Hai-Qiang Mai
Yan-Fen Feng
Ellen T. Chang
Chen-Ping Wang
Michael Koon Ming Kam
Shie-Lee Cheah
Ming Lee
Li Gao
Hui-Zhong Zhang
Jie-Hua He
Hao Jiang
Pei-Qing Ma
Xiao-Dong Zhu
Liang Zeng
Chun-Yan Chen
Gang Chen
Ma-Yan Huang
Sha Fu
Qiong Shao
An-Jia Han
Hai-Gang Li
Chun-Kui Shao
Pei-Yu Huang
Chao-Nan Qian
Tai-Xiang Lu
Jin-Tian Li
Weimin Ye
Ingemar Ernberg
Ho Keung Ng
Joseph T. S. Wee
Yi-Xin Zeng
Hans-Olov Adami
Anthony T. C. Chan
Jian-Yong Shao
A new prognostic histopathologic classification of nasopharyngeal carcinoma
Chinese Journal of Cancer
Nasopharyngeal carcinoma
Pathologic classification
Prognosis
title A new prognostic histopathologic classification of nasopharyngeal carcinoma
title_full A new prognostic histopathologic classification of nasopharyngeal carcinoma
title_fullStr A new prognostic histopathologic classification of nasopharyngeal carcinoma
title_full_unstemmed A new prognostic histopathologic classification of nasopharyngeal carcinoma
title_short A new prognostic histopathologic classification of nasopharyngeal carcinoma
title_sort new prognostic histopathologic classification of nasopharyngeal carcinoma
topic Nasopharyngeal carcinoma
Pathologic classification
Prognosis
url http://link.springer.com/article/10.1186/s40880-016-0103-5
work_keys_str_mv AT haiyunwang anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT yihleongchang anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT kafaito anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT jacquelinesghwang anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT haiqiangmai anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT yanfenfeng anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT ellentchang anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT chenpingwang anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT michaelkoonmingkam anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT shieleecheah anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT minglee anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT ligao anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT huizhongzhang anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT jiehuahe anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT haojiang anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT peiqingma anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT xiaodongzhu anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT liangzeng anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT chunyanchen anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT gangchen anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT mayanhuang anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT shafu anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT qiongshao anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT anjiahan anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT haigangli anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT chunkuishao anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT peiyuhuang anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT chaonanqian anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT taixianglu anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT jintianli anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT weiminye anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT ingemarernberg anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT hokeungng anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT josephtswee anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT yixinzeng anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT hansolovadami anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT anthonytcchan anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT jianyongshao anewprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT haiyunwang newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT yihleongchang newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT kafaito newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT jacquelinesghwang newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT haiqiangmai newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT yanfenfeng newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT ellentchang newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT chenpingwang newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT michaelkoonmingkam newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT shieleecheah newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT minglee newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT ligao newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT huizhongzhang newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT jiehuahe newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT haojiang newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT peiqingma newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT xiaodongzhu newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT liangzeng newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT chunyanchen newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT gangchen newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT mayanhuang newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT shafu newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT qiongshao newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT anjiahan newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT haigangli newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT chunkuishao newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT peiyuhuang newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT chaonanqian newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT taixianglu newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT jintianli newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT weiminye newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT ingemarernberg newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT hokeungng newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT josephtswee newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT yixinzeng newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT hansolovadami newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT anthonytcchan newprognostichistopathologicclassificationofnasopharyngealcarcinoma
AT jianyongshao newprognostichistopathologicclassificationofnasopharyngealcarcinoma